Brief: Clarity Pharmaceuticals And Nucleus Radiopharma Sign Master Services Agreement
11/11/2024 01:29
Nov 11 (Reuters) - Clarity Pharmaceuticals CU6.AX :
* CLARITY AND NUCLEUS RADIOPHARMA SIGN MASTER SERVICES
AGREEMENT &
CU-67 SAR-BISPSMA CLINICAL SUPPLY AGREEMENT
Further company coverage: CU6.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clarity Pharmaceuticals
See all newsBrief: Clarity Pharmaceuticals Signs Commercial Manufacturing Agreement
Brief: Clarity Signs A Large-Scale Manufacturing Supply Agreement For Copper-64 With Theragenics
Brief: Clarity Pharmaceuticals Signs A Large-Scale Manufacturing Supply Agreement
Australia's Clarity Pharmaceuticals rises on bagging cancer detection agent supply
Australia's Clarity Pharma surges as US FDA approves trial